The use of gadolinium-based contrast agents (GBCAs) for MRI exams is the centerpiece of an article published on 6 July in the popular German news magazine Der Spiegel.
Several studies have demonstrated the capacity of the brain and other tissues to retain gadolinium, potentially harming patients receiving GBCAs. The repeated occurrence of this retention has led to increased awareness among the general public in Germany and prompted new concerns over patient safety, according to the article.
